Obesity Surgery · Nov 13, 2026
Weight, Fat Mass, and Lean Mass Changes After Bariatric Surgery and GLP-1–Based Therapy: A Systematic Review and Meta-Analysis
By Urbina J, Scott J, Prieto Aldape MR et al.
Metabolic and bariatric surgery (MBS) and GLP-1–based therapies both reduce weight, but their effects on body composition are not directly comparable across measurement methods. We systematically reviewed 31 studies; 30 studies comprising 5,616 participants were included in random-effects meta-analyses stratified by dual-energy X-ray absorptiometry or bioelectrical impedance analysis, with 12 months as the primary timepoint. In both modalities, MBS was associated with greater total weight and absolute fat-mass loss than GLP-1–based therapy. Greater absolute lean-mass loss accompanied the larger weight reduction, without establishing poorer proportional lean-mass preservation. Relative fat-mass change differed by modality, and heterogeneity was substantial. These indirect subgroup comparisons should not be interpreted as head-to-head treatment effects. Standardized comparative studies incorporating muscle strength and physical function are needed.
doi.org/10.1007/s11695-026-09024-2PubMed 43024141Interventions